Department of Nephrology, Hospital Clínic Barcelona, Barcelona, Spain.
Department of Medicine, University of Barcelona, Barcelona, Spain.
Artif Organs. 2024 Jul;48(7):753-762. doi: 10.1111/aor.14726. Epub 2024 Feb 26.
New versions of the polyester polymer alloy (PEPA) membrane have appeared over the years, with increases in both the pore size and the amount of polyvinylpyrrolidone (PVP) to optimize hydrophilicity performance. This study aimed to assess the efficacy of the most recently developed PEPA dialyzer, the FDY series, in hemodialysis (HD) modality in terms of uremic toxin removal and albumin loss and to compare it with that of several high-flux dialyzers currently used in HD and post-dilution hemodiafiltration (HDF) treatments.
A prospective study was carried out in 21 patients. All patients underwent six dialysis sessions with the same routine dialysis parameters; only the dialyzer and/or the dialysis modality varied: FX80 in HD, FDY 180 in HD, Clearum HS17 in HDF, Elisio 19H in HDF, Vitapes 180 in HDF, and FX80 in post-dilution HDF. The reduction ratios (RR) of urea, creatinine, ß-microglobulin, myoglobin, κFLC, prolactin, α-microglobulin, α-acid glycoprotein, λFLC, and albumin were compared intraindividually. Dialysate albumin loss was also measured.
Both membranes FDY and FX80 are high-flux dialyzers and are applied here in high-flux HD. The average RR of β-microglobulin was slightly lower in the two HD treatments than in the HDF treatments. Comparison of dialysis treatments revealed that the PEPA FDY dialyzer in the HD modality was more effective than the FX80 dialyzer in high-flux HD and was as effective as post-dilution HDF, especially in terms of myoglobin, κFLC, prolactin, α-microglobulin, and λFLC RRs. The FDY treatments obtained similar albumin RR in blood and slightly higher dialysate albumin loss, although the values were clinically acceptable.
The most recently developed PEPA dialyzers in the HD modality were as effective as all treatments in the HDF modality and were clearly superior to high-flux helixone HD treatment. These results confirm that this dialyzer should be categorized within the medium cut-off (MCO) membrane classification.
多年来,聚酯聚合物合金(PEPA)膜的新版本不断出现,其孔径和聚乙烯吡咯烷酮(PVP)的含量都有所增加,以优化其亲水性性能。本研究旨在评估最新开发的 PEPA 透析器 FDY 系列在血液透析(HD)模式下的尿素清除率和白蛋白丢失效果,并将其与目前在 HD 和后稀释血液透析滤过(HDF)治疗中使用的几种高通量透析器进行比较。
进行了一项前瞻性研究,共纳入 21 名患者。所有患者均接受了六次相同常规透析参数的透析治疗;仅改变透析器和/或透析模式:HD 中使用 FX80、HD 中使用 FDY180、HDF 中使用 Clearum HS17、HDF 中使用 Elisio 19H、HDF 中使用 Vitapes 180 和后稀释 HDF 中使用 FX80。比较了个体内尿素、肌酐、β-微球蛋白、肌红蛋白、κFLC、催乳素、α-微球蛋白、α-酸性糖蛋白、λFLC 和白蛋白的清除率(RR)。还测量了透析液中的白蛋白丢失。
FDY 和 FX80 两种膜均为高通量透析器,本研究将其应用于高通量 HD 中。两种 HD 治疗中β-微球蛋白的平均 RR 略低于 HDF 治疗。与透析治疗相比,HD 模式下的 PEPA FDY 透析器比 FX80 透析器在高通量 HD 中更有效,与后稀释 HDF 同样有效,尤其是在肌红蛋白、κFLC、催乳素、α-微球蛋白和 λFLC 的 RR 方面。FDY 治疗在血液中获得了相似的白蛋白 RR,并略微增加了透析液中的白蛋白丢失,但这些值在临床可接受范围内。
HD 模式下最新开发的 PEPA 透析器与 HDF 模式下的所有治疗方法一样有效,明显优于高通量螺旋 HD 治疗。这些结果证实,该透析器应归类于中分子量截止(MCO)膜分类。